SCHEMBL3351759

SCHEMBL3351759

O=C(O)C(F)(F)I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854427 0.96
SCHEMBL4849399 0.96
SCHEMBL5162473 0.83
SCHEMBL10386372 0.80
SCHEMBL5610978 0.80 ALDH1A1 (0.38)
SCHEMBL12964992 0.77
SCHEMBL28610373 0.77 ALDH1A1 (0.36)
SCHEMBL4855210 0.75
SCHEMBL28682093 0.75 CA2 (0.30)
SCHEMBL4855996 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688154-A1 MORPHOLINE OREXIN RECEPTOR ANTAGONISTS BIAL - Portela & Ca., S.A. (PT) 2026-02-11 EP claimed
WO-2025023851-A1 MORPHOLINE OREXIN RECEPTOR ANTAGONISTS BIAL - PORTELA & CA., S.A. (PT) 2025-01-30 WO claimed
JP-2067250-A None JP disclosed
JP-3027323-A None JP disclosed
EP-4688154-A1 MORPHOLINE OREXIN RECEPTOR ANTAGONISTS BIAL - Portela & Ca., S.A. (PT) 2026-02-11 EP disclosed
WO-2025023851-A1 MORPHOLINE OREXIN RECEPTOR ANTAGONISTS BIAL - PORTELA & CA., S.A. (PT) 2025-01-30 WO disclosed
US-12187694-B2 SLC26A3 inhibitors and use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-07 US disclosed
US-20230339878-A1 SLC26A3 INHIBITORS AND USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-10-26 US disclosed
EP-3612180-B1 SUBSTITUTED 2-ACYLAMINO-CYCLOALKYLTHIOPHENE-3-CARBOXYLIC ACID ARYLAMIDES AS INHIBITORS OF CALCIUM-ACTIVATED CHLORIDE CHANNEL TMEM16A UNIV CALIFORNIA (US) 2023-10-11 EP disclosed
CN-116621756-A Preparation method of 3, 3-difluoro-gamma-lactam compound 遵义医科大学 2023-08-22 CN disclosed
WO-2023147328-A1 ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION WITH HYDOLYSABLE MALEIMIDE LINKERS AND METHODS THEREOF GENENTECH, INC. (US) 2023-08-03 WO disclosed
WO-2000059503-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-10-12 WO disclosed
EP-0812308-A4 METHOD FOR SYNTHESIS OF ARYL DIFLUOROMETHYL ETHERS AND THE LIKE SMITHKLINE BEECHAM CORP (US) 1999-03-31 EP disclosed
US-5731477-A Method for synthesis of aryl difluoromethyl ethers SMITHKLINE BEECHAM CORPORATION (US) 1998-03-24 US disclosed
EP-0812308-A1 METHOD FOR SYNTHESIS OF ARYL DIFLUOROMETHYL ETHERS AND THE LIKE SMITHKLINE BEECHAM CORPORATION (US) 1997-12-17 EP disclosed
US-5583147-A INHIBITORS OF ACYL-COENZYME A: CHOLESTEROL O-TRANSFERASE; ANTIHYPERCHOLESTEROLEMIC AND/OR ANTIATHEROSCLEROTIC AGENTS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-10 US disclosed
WO-1996023754-A1 METHOD FOR SYNTHESIS OF ARYL DIFLUOROMETHYL ETHERS AND THE LIKE SMITHKLINE BEECHAM CORPORATION (US) 1996-08-08 WO disclosed
JP-H0327323-A NOVEL PRODUCTION OF 2,2-DIFLUOROCARBOXYLIC ACID DERIVATIVE ASAHI GLASS CO LTD 1991-02-05 JP disclosed
JP-H0267250-A PRODUCTION OF 2,2-DIFLUORO-3-HYDROXYCARBOXYLIC ACID DERIVATIVE ASAHI GLASS CO LTD 1990-03-07 JP disclosed
US-4318867-A FROM TETRAFLUORO-1,2-DIIODO ETHANE, BY OXIDATION WITH SULFUR TRIOXIDE, SULFURIC ACID, CHLOROSULFONIC ACID OR FLUOROSULFONIC ACID ASAHI GLASS COMPANY, LTD. (JP) 1982-03-09 US disclosed